Fred Khosravi & Amar Sawhney: Dynamic Device Development Duo
Article perview reprinted from IN VIVO - June 2009
Located on opposite coasts and with complementary skill sets, Fred Khosravi, founder of EndoTex, teamed up with Amar Sawhney, founder of Confluent Surgical, to form Incept, which has become a powerful device company creation engine. Using a unique formula that launches new companies building on previous successes, Incept has compiled an enviable record, starting nine companies in 11 years with three exits and no failures. Read more...
Fred Khosravi & Amar Sawhney: Dynamic Device Development Duo
Article perview reprinted from IN VIVO - June 2009
Incubators have a checkered history in the device industry. It is not uncommon for a serial entrepreneur, coming off one or two successful exits, to create an organization that attempts to capture his or her formula for launching new device companies. (Actually, the word incubator has become passé so the first thing the entrepreneur typically does is come up with a creative synonym for incubator—accelerator is a recent favorite.) Unfortunately, the process of company creation has proven generally to be difficult to package and pass along to future start-ups with any reliable degree of success, resulting in a mixed record for device incubators.
One such organization, however, appears to be building an enviable track record while flying under the radar of many industry observers. Indeed, Incept, which is the joint product of veteran device entrepreneurs Fred Khosravi and Amar Sawhney, PhD, (who prefer "enabler" to "incubator") operates in near-virtual status. Yet, since being founded in 1998, Incept has launched 11 companies (see Exhibit 1 in "Interview with Amar Sawhney," this issue and has had three successful exits and no failures.
Purchase this 1,503-word article online for $85 or get it FREE when you subscribe to IN VIVO
Your satisfaction is guaranteed.
Companies mentioned in this article:
AccessClosure Inc.
Boston Scientific Corp.
Guidant Corp.
Covidien Ltd.
Confluent Surgical Inc.
Genzyme Corp.
Sadra Medical Inc.
SquareOne Inc.
Stanford University
Related articles:
Interview with Fred Khosravi
By David Cassak, In Vivo 06/2009
Vascular Access Closure Ten Years Later: Why Start-Ups Can't Seal the Deal
By Mary Stuart, Start-Up 12/2008
About IN VIVO:
IN VIVO is the premier strategic business resource for the biopharma, medtech, and diagnostics industries.
IN VIVO delivers:
-
Revealing, in-depth coverage of your competitors' strategies
- Incisive projections of future industry trends and their implications for your business
- Expert analysis of key industry developments
- Exclusive interviews with top industry executives and analysts
- In-depth examination of dealmaking, marketing, R&D, regulatory, and finance strategies -- those that were successful and those that missed the mark
For more information contact Sean Smith at 240-221-4535 or [email protected]
